6.415
Journey Medical Corp Aktie (DERM) Neueste Nachrichten
Journey Medical Corp Appoints New Chief Operating Officer - TipRanks
Q1 EPS Estimates for Journey Medical Reduced by Roth Capital - MarketBeat
Journey Medical appoints new COO amid growth phase - Investing.com
Journey Medical Strengthens Leadership: New COO to Drive Emrosi Launch Strategy - Stock Titan
Journey Medical (NASDAQ:DERM) Issues Earnings Results - MarketBeat
Q3 EPS Estimates for Journey Medical Boosted by Roth Capital - MarketBeat
FY2027 EPS Estimate for Journey Medical Decreased by Analyst - Defense World
FY2027 EPS Estimates for Journey Medical Reduced by Analyst - MarketBeat
Roth Capital Lowers Earnings Estimates for Journey Medical - Defense World
Q3 EPS Estimates for Journey Medical Increased by Analyst - Defense World
Journey Medical Corporation (NASDAQ:DERM) Q4 2024 Earnings Call Transcript - Insider Monkey
Journey Medical Reports 2024 Financial Results - TipRanks
Journey Medical’s Earnings Call Highlights MROSI Launch and Growth Potential - TipRanks
Journey Medical Corp (DERM) Q4 2024 Earnings Call Highlights: Strategic Launch of Emrosi and ... By GuruFocus - Investing.com Canada
Journey Medical earnings beat by $0.27, revenue fell short of estimates - Investing.com
Earnings call transcript: Journey Medical Q4 2024 reveals revenue miss By Investing.com - Investing.com South Africa
Earnings call transcript: Journey Medical Q4 2024 reveals revenue miss - Investing.com India
Earnings call transcript: Journey Medical’s Q4 2024 results highlight IMROCI launch - Investing.com
Journey Medical Corporation (DERM) Tops Q4 Earnings Estimates - Yahoo Finance
Journey Medical reports FY24 EPS (72c) vs (21c) last year - TipRanks
Journey Medical Corp reports results for the quarter ended December 31Earnings Summary - TradingView
FDA Green Light for Journey Medical's Rosacea Drug Reshapes 2024 Performance - Stock Titan
Earnings Scheduled For March 26, 2025 - Benzinga
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights - Yahoo Finance
New Study Compares Topical Serum and Pulse Light Therapy for Rosacea - Dermatology Times
Journey Medical launches Emrosi for the treatment of rosacea - Yahoo Finance
Power Up the Teyvat Journey: UGREEN Launches Genshin Impact Co-Branded Charging Collection - Yahoo Finance
23andMe's journey from DNA testing pioneer to bankruptcy - Yahoo Finance
Journey Medical Launches Emrosi, a Dual-Release Minocycline for Rosacea - Dermatology Times
Breakthrough: First Low-Dose Minocycline Treatment for Rosacea Shows Superior Results - Stock Titan
Short Interest in Journey Medical Co. (NASDAQ:DERM) Grows By 20.5% - MarketBeat
Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025 - Yahoo Finance
Journey Medical Sets Date for 2024 Annual Results: Dermatology Leader's Financial Update - Stock Titan
Journey Medical (DERM) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Claude Maraoui Sells 49,271 Shares of Journey Medical Co. (NASDAQ:DERM) Stock - MarketBeat
Journey Medical Co. (NASDAQ:DERM) CEO Sells $74,674.05 in Stock - MarketBeat
Journey Medical (DERM) to Release Quarterly Earnings on Thursday - Defense World
Stocks Rally as US Consumer Prices Cool - The Globe and Mail
Journey Medical Corporation to Participate in the 37th Annual ROTH Conference - The Manila Times
Journey Medical CEO Sets Stage for Major Updates at ROTH Conference - StockTitan
Journey Medical’s CEO sells $246,847 in stock By Investing.com - Investing.com South Africa
CEO Cashes Out: Major Stock Sale at Journey Medical Corp - TipRanks
Journey Medical’s CEO sells $246,847 in stock - Investing.com India
Journey Medical CEO Claude Maraoui sells shares worth $203,451 By Investing.com - Investing.com Canada
Journey Medical CEO Claude Maraoui sells shares worth $203,451 - Investing.com Australia
Journey Medical Co. (NASDAQ:DERM) CEO Sells $122,006.52 in Stock - MarketBeat
Claude Maraoui Sells 18,147 Shares of Journey Medical Co. (NASDAQ:DERM) Stock - MarketBeat
Dario Expands Behavioral Health Offerings to Include a Provider Network Through Strategic Arrangement with Rula - PR Newswire
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):